Cancer Gene Therapy - Table of Contents alert Volume 22 Issue 4

If you are unable to see the message below, click here to view.

Advertisement Save up to 35% on your oligo costs. Introducing AUM's next generation oligo technology for efficient RNA silencing and regulation. Superior potency, delivery, stability & binding affinity. Reduced toxicity, immune stimulation & off target effects. Order oligos today for: • Gene silencing • Exon skipping • Translation elongation inhibition (Steric blockers) • microRNA regulation (Antagomirs) • lncRNA and other non-coding RNA regulation • Decoys or Blockers. TABLE OF CONTENTS Volume 22, Issue 4 ( April 2015) In this issue Editorial Review Original Articles Corrigendum Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top Oncolytic viruses: focusing on the tumor microenvironment C R de Vries, H L Kaufman and E C Lattime Cancer Gene Ther 2015 22: 169-171; advance online publication, February 27, 2015; 10.1038/cgt.2015.11 Full Text Review Top Gene therapy for radioprotection W H Everett and D T Curiel Cancer Gene Ther 2015 22: 172-180; advance online publication, February 27, 2015; 10.1038/cgt.2015.8 Abstract | Full Text Original Articles Top Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice Z Xu, Y Dong, F Peng, Z Yu, Y Zuo, Z Dai, Y Chen, J Wang, X Hu, Q Zhou, H Ma, Y Bao, G Gao and M Chen Cancer Gene Ther 2015 22: 181-187; advance online publication, January 16, 2015; 10.1038/cgt.2014.79 Abstract | Full Text Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing Y Terasawa, T Hotani, Y Katayama, M Tachibana, H Mizuguchi and F Sakurai Cancer Gene Ther 2015 22: 188-197; advance online publication, January 30, 2015; 10.1038/cgt.2015.4 Abstract | Full Text Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer Z Zhang, J Huang, C Zhang, H Yang, H Qiu, J Li, Y Liu, L Qin, L Wang, S Hao, F Zhang, X Wang and B Shan Cancer Gene Ther 2015 22: 198-206; advance online publication, February 27, 2015; 10.1038/cgt.2015.7 Abstract | Full Text Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies W H Shuen, R Kan, Z Yu, H L Lung and M L Lung Cancer Gene Ther 2015 22: 207-214; advance online publication, February 27, 2015; 10.1038/cgt.2015.9 Abstract | Full Text Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein K A Lears, J J Parry, R Andrews, K Nguyen, T J Wadas and B E Rogers Cancer Gene Ther 2015 22: 215-221; advance online publication, April 3, 2015; 10.1038/cgt.2015.14 Abstract | Full Text Corrigendum Top Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor M S Beatty, L Timares and D T Curiel Cancer Gene Ther 2015 22: 222; 10.1038/cgt.2015.13 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.